platinum has been researched along with Neoplasms, Squamous Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Dam, A; Bräutigam, L; Geisslinger, G; Kovács, AF; Seegel, M; Tegeder, I; Turowski, B | 1 |
| Andrews, PA; Cullen, KJ; Ellison, CD; Faustino, PJ; Monastra, R; Rasmussen, AA; Yang, Z | 1 |
1 trial(s) available for platinum and Neoplasms, Squamous Cell
| Article | Year |
|---|---|
Cisplatin tumor concentrations after intra-arterial cisplatin infusion or embolization in patients with oral cancer.
Topics: Adult; Aged; Antidotes; Antineoplastic Agents; Area Under Curve; Calibration; Catheterization; Cisplatin; Embolization, Therapeutic; Female; Humans; Infusions, Intra-Arterial; Male; Microdialysis; Middle Aged; Mouth Neoplasms; Neoplasms, Squamous Cell; Platinum; Thiosulfates | 2003 |
1 other study(ies) available for platinum and Neoplasms, Squamous Cell
| Article | Year |
|---|---|
Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell lines.
Topics: Antineoplastic Agents; Apoptosis; Cell Line; Cisplatin; DNA Adducts; DNA Repair; Drug Resistance, Neoplasm; Glutathione; Head and Neck Neoplasms; Humans; Neoplasms, Squamous Cell; Platinum; Spectrophotometry, Atomic; Tumor Cells, Cultured | 2000 |